News & Updates
-
OCRFA is now OCRA
(October 1, 2018) We’re shortening our name, to make it easier to say and easier to write. OCRFA is now Ovarian Cancer Research Alliance (OCRA). You can find us at ocrahope…
-
Maintenance olaparib Improves Progression-Free Survival in Phase III Clinical Trial
(October 23, 2018) Olaparib, or Lynparza, was shown to increase progression-free survival (PFS) by almost three years in an ongoing trial known as SOLO-1…
-
OCRA Research Shows How Cancer Cells Negatively Impact the Communication between the Ovary and Fallopian Tube
(October 22, 2018) A team at the University of Illinois at Chicago, including OCRA grantee Matthew Dean, PhD, recently discovered the role that cancer cells have on their immediate environment…
-
Kunle Odunsi, MD, PhD, Elected to National Academy of Medicine
(October 18, 2018) Longtime OCRA Scientific Advisory Committee member and former grantee Kunle Odunsi, MD, PhD, has been elected to the National Academy of Medicine—a distinguished lifetime…
-
OCRA Funded Research Reveals Immune Suppression in Ovarian Cancer
(October 15, 2018) This month in Nature, researchers from Weill Cornell published a study that helps to explain why the body’s natural immune response struggles to fight back against ovarian…
-
For Some, Statin Use Can Decrease the Risk of Ovarian Cancer
(November 13, 2018) The International Journal of Cancer recently published a study that explored the use of statins, which reduces one’s lipids, and their effect on ovarian cancer risk…
Help Save Women's Lives
Our Impact
-
Invested over $80M
in ovarian cancer research since 1994
-
Educated 75,000+
future medical professionals since 2002
-
Advocated for $150M+
in government research funding in 2017
Fundraise for OCRA
-
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
-
Ovarian Cycle
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!